Ginsenoside Rh1 Modulates GABAergic Inhibitory Homeostasis and Mitochondrial Quality Control During Lead (Pb)-Associated Neuronal Dysfunction
Molecules · 11.08.2026 · 31 (16) · 2801
DOI: 10.3390/molecules31162801 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 11.08.2026. Verfasst von Xiang Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Basic Medical Sciences, The Medical Basic Research Innovation Center of Airway Disease in North China, Key Lab…. Hauptthemen laut MEDLINE: Ginsenosides, Mitochondria, gamma-Aminobutyric Acid, Neurons. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jilin Province Science and Technology Department, Jilin University.
Abstract (Originalsprache)
Disruption of neuronal excitation–inhibition balance and mitochondrial quality control may contribute importantly to lead (Pb)-induced neurotoxicity, but nutritional modulators targeting these processes remain poorly characterized. This study investigated the protective effects and underlying mechanisms of ginsenoside Rh1, a ginseng-derived bioactive compound, in Pb-exposed mice and Pb-treated HT22 hippocampal cells. Chronic Pb exposure caused spatial recognition deficits, reduced exploratory activity, anxiety-like behaviors, and marked neuronal injury, accompanied by Pb accumulation in blood and brain tissues, elevated IL-1β, TNF-α, and IL-6 levels, oxidative stress, reduced Gama-aminobutyric acid (GABA) content, and dysregulated NKCC1/KCC2 expression. In HT22 cells, Pb increased intracellular ROS generation and disrupted mitophagy-related signaling, as indicated by alterations in PINK1, Parkin, LC3, P62, and GABARAP. Rh1 treatment alleviated Pb-induced behavioral abnormalities and neuronal pathology, reduced Pb burden, suppressed neuroinflammatory responses, enhanced antioxidant defenses, improved Pb-associated alterations in GABAergic regulation, and modulated mitochondrial quality-control signaling in vivo and in vitro. These findings suggest that Rh1 may represent a promising nutritional intervention strategy for mitigating Pb-associated neurotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, College of Basic Medical Sciences, The Medical Basic Research Innovation Center of Airway Disease in North China, Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Chan…
- Ginseng Research Institute, Jilin University, Changchun 130021, China.
- College of Food Science and Engineering, Jilin University, Changchun 130062, China.
- School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China.
- School of Pharmaceutical Sciences, Changchun University of Chinese Medicine, Changchun 130000, China.
ORCID-Profile: Xiang Li
Förderung
- Jilin Province Science and Technology Department
- Jilin University
Zitieren
APA
Li, X., Wang, T., Mo, L., Cao, H., Lv, Z., Yu, J., Liu, S., Sun, Y., & Chen, T. (2026). Ginsenoside Rh1 Modulates GABAergic Inhibitory Homeostasis and Mitochondrial Quality Control During Lead (Pb)-Associated Neuronal Dysfunction. Molecules, 31(16), 2801. https://doi.org/10.3390/molecules31162801
Vancouver
Li X, Wang T, Mo L, Cao H, Lv Z, Yu J, et al. Ginsenoside Rh1 Modulates GABAergic Inhibitory Homeostasis and Mitochondrial Quality Control During Lead (Pb)-Associated Neuronal Dysfunction. Molecules. 2026;31(16):2801. doi:10.3390/molecules31162801
BibTeX
@article{Li2026,
author = {Li, Xiang and Wang, Tingting and Mo, Linfeng and Cao, Huixin and Lv, Zhongting and Yu, Jia and Liu, Shuang and Sun, Yantong and Chen, Tianli},
title = {Ginsenoside Rh1 Modulates GABAergic Inhibitory Homeostasis and Mitochondrial Quality Control During Lead (Pb)-Associated Neuronal Dysfunction},
journal = {Molecules},
year = {2026},
volume = {31},
number = {16},
pages = {2801},
doi = {10.3390/molecules31162801}
}
EUVIMED